Impact of Cardiac Computed Tomographic Angiography Findings on Planning of Cancer Therapy in Patients with Concomitant Structural Heart Disease

<table class="table-group" id="tab6"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Cancer treatment decisions</td><td align="center"><i>N</i> (%)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Proceed with chemotherapy</td><td align="center">19 (23.8)</td></tr><tr><td align="left">Proceed with stem cell transplant evaluation</td><td align="center">8 (10.0)</td></tr><tr><td align="left">Proceed with cancer surgery</td><td align="center">3 (3.8)</td></tr><tr><td align="left">Proceed with radiation therapy</td><td align="center">2 (2.5)</td></tr><tr><td align="left">Change chemotherapy agents due to cardiomyopathy</td><td align="center">7 (8.8)</td></tr><tr><td align="left">Hold chemotherapy for invasive coronary angiography</td><td align="center">2 (2.5)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

 Impact of cardiac computed tomographic angiography on cancer-related treatment decisions.

Cardiology Research and Practice

tab6

Table 6

Table 6: Impact of Cardiac Computed Tomographic Angiography Findings on Planning of Cancer Therapy in Patients with Concomitant Structural Heart Disease 

Table 6 | Impact of Cardiac Computed Tomographic Angiography Findings on Planning of Cancer Therapy in Patients with Concomitant Structural Heart Disease 